STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF REPAGLINIDE IN RABBIT PLASMA
DOI:
https://doi.org/10.22159/ijap.2019v11i3.33675Keywords:
HPLC-UV, Repaglinide, Bioanalytical, Validation, Rabbit plasmaAbstract
Objective: A simple, selective and sensitive reverse-phase high-performance liquid chromatography (RP-HPLC) method to estimate repaglinide (REP) in rabbit plasma using rabeprazole (RAB) as an internal standard was developed and validated for various qualifications.
Methods: The chromatographic separation was performed on C18 (2) analytical column (5 μ, 250×4.6 mm) using acetonitrile: 0.05% trifluoroacetic acid in water (55:45, v/v) as mobile phase at the flow rate of 1 ml/min. Validation of the analytical method was performed as per ICH guidelines.
Results: The retention times of REP and RAB were found at ~4.3 and 5.1 min respectively, with adequate system suitability parameters (theoretical plates ≥3619, tailing factor ≤1.38, resolution factor 2.37). The method has linearity over a concentration range of 10 to 1000 ng/ml (r2=0.9987). The results of accuracy (≥98.17%), intra-, inter-day precision (≤2.9%), recovery (101.21±2.09%) and process efficiency (99.77±3.74%) found satisfactory with no matrix effect. The analyte in samples were found stable up to 6 h, 3 freeze-thaw cycles and not more than 2 mo corresponding to bench-top, short and long term stability studies respectively.
Conclusion: The developed RP-HPLC method for estimation of REP in rabbit plasma was developed. The method was found to be rapid, cost-effective and accurate to estimate the REP from the sample matrix. The method can be a most useful tool for in vivo study of REP in the rabbit.
Downloads
References
Marbury TM, Ruckle JL, Hatorp V, Andersen MP, Nielsen KK, Huang WC, et al. Pharmacokinetic of repaglinide in subjects with renal impairment. Clin Pharmacol Ther 2000;67:7-15.
Scott LJ. Repaglinide. Drugs 2012;72:249-72.
Kassem AA, El-Alim SHA, Basha M, Salama A. Phospholipid complex enriched micelles: a novel drug delivery approach for promoting the antidiabetic effect of repaglinide. J Pharm Sci 2017;99:75-84.
Stephan D, Winkler M, Kuhner P, Russ U, Quast U. Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular KATP channels. Diabetologia 2006;49:2039-48.
Jirovsky D, Bartosova Z, Skopalova J, Maier V. Electrochemical characterization of repaglinide and its determination in human plasma using liquid chromatography with dual-channel coulometric detection. J Chrom B 2010;878:3243-8.
Hatorp V, Huang WC, Strange P. Repaglinide pharmacokinetics in healthy young adult and elderly subjects. Clin Ther 1999;21:702–10.
Greischel A, Beschke K, Rapp H, Roth W. Quantitation of the new hypoglycaemic agent AG-EE388ZW in human plasma by automated high-performance liquid chromatography with electrochemical detection. J Chrom B 1991;568:246-52.
Yao J, Shi YQ, Li ZR, Jin SH. Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs. J Chrom B 2007;853:254-9.
Venkatesh P, Harisudhan T, Choudhury H, Mullangi R, Srinivas NR. Simultaneous estimation of six anti-diabetic drugs glibenclamide, gliclazide, glipizide, pioglitazone, repaglinide and rosiglitazone: development of a novel HPLC method for use in the analysis of pharmaceutical formulations and its application to human plasma assay. Biomed Chrom 2006;20:1043-8.
Ruzilawati AB, Abd Wahab MS, Imran A, Ismail Z, Gan SH. Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies. J Pharm Biomed Anal 2007;43:1831-5.
Zhang J, Gao F, Guan X, Sun Y, Gu J, Fawcett JP. Determination of repaglinide in human plasma by high-performance liquid chromatography-tandem mass spectrometry. Acta Pharm Sin B 2011;1:40-5.
Wang M, Miksa IR. Multi-component plasma quantitation of anti-hyperglycemic pharmaceutical compounds using liquid chromatography-tandem mass spectrometry. J Chrom B 2007;856:318–27.
Sharma K, Pawar G, Yadam S, Giri S, Rajagopal S, Mullangi R. LC-MS/MS-ESI method for simultaneous quantitation of metformin and repaglinidie in rat plasma and its application to pharmacokinetic study in rats. Biomed Chrom 2013;27:356-64.
Ho EN, Yiu KC, Wan TS, Stewart BD, Watkins KL. Detection of anti-diabetics in equine plasma and urine by liquid chromatography-tandem mass spectrometry. J Chrom B 2004;811:65-73.
Gandhimathi M, Ravi TK, Renu SK. Determination of repaglinide in pharmaceutical formulations by HPLC with UV detection. Anal Sci 2003;19:1675-7.
Berecka A, Gumieniczek A, Hopkala H. Development and validation of a new high-performance liquid chromatography method for the determination of gliclazide and repaglinide in pharmaceutical formulations. J AOAC Int 2006;89:319-25.
Joshi SS, Nahire RR, Shastri NR, Surendranath KV, Satish J. Validated stability-indicating RP-HPLC UV method for simultaneous determination of metformin and repaglinide. Acta Chrom 2012;24:419-43.
Soni LK, Narsinghani T, Jain M. Development and validation of RP-HPLC method for simultaneous estimation of metformin hydrochloride and repaglinide in tablet dosage form. J Liq Chromatogr Relat Technol 2012;35:385-92.
Yin K, Meng X, Dong P, Ding T, Shen L, Zhang L, et al. A simple, rapid, economical, and practical method for the determination of efavirenz in plasma of Chinese AIDS patients by reverse-phase high-performance liquid chromatography with ultraviolet detector. BioSci Trends 2014;8:227-34.
Ma Z, Shayeganpour A, Brocks DR, Lavasanifar A, Samuel J. High-performance liquid chromatography analysis of curcumin in rat plasma: application to the pharmacokinetics of polymeric micellar formulation of curcumin. Biomed Chrom 2007;21:546–52.
ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2 (R1). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Geneva; 2005. p. 1-13.
Guidance for industry: bioanalytical method validation, U. S. Department of health and human services, Food and Drug administration, Centre for Drug Evaluation and Research (CDER) Centre for Veterinary Medicine (CVM); 2018. p. 1-41.
Jimmerson LC, Zheng JH, Bushman LR, MacBrayne CE, Anderson PL, Kiser JJ. Development and validation of a dried blood spot assay for the quantification of ribavirin using liquid chromatography coupled to mass spectrometry. J Chrom B 2014;944:18–24.
Bansal S, DeStefano A. Key elements of bioanalytical method validation for small molecules. AAPS J 2007;9:109-14.
Shanmugasundaram P, Bijithra C, Ragan G, Sankar A, Sumithra M. Analyitcal method development and validation of reversed-phase high-performance liquid chromatography for the determination of modafinil in bulk and pharmaceutical dosage forms. Asian J Pharm Clin Res 2016;9:177-81.
Ashok P, Narenderan ST, Meyyanathan SN, Babu B, Vadivelan R. Development and validation of a RP-HPLC method for estimation of telmisartan in human plasma. Int J Appl Pharm 2019;11:237-40.
Mukti AA, Jannah F, Nurrochmad A, Lukitaningsih E. Development and validation method for quantitative determination of ciprofloxacin in human plasma and its application in bioequivalence test. Asian J Pharm Clin Res 2016;9:89-95.
Published
How to Cite
Issue
Section
